Our data are in accordance with this literature, and in particular, the effect of KRX-C7 to reduce mRNA of SERCA2a confirms the maladaptive upregulation of SERCA2a in diabetes, and the effectiveness of GRK2 inhibition to correct such a feature. The gene discussed is GRK2; the disease is diabetes mellitus.